Literature DB >> 8279644

Induction of protective immunity against larval Onchocerca volvulus in a mouse model.

A M Lange1, W Yutanawiboonchai, J B Lok, M Trpis, D Abraham.   

Abstract

BALB/cBYJ mice were immunized against larval Onchocerca volvulus by subcutaneous injection of normal, irradiated, or freeze-thaw-killed Onchocerca sp. larvae. The mice received challenge infections of O. volvulus third-stage larva (L3) contained in diffusion chambers implanted subcutaneously. At two-weeks postinfection, the diffusion chambers were removed and larval survival was assessed. When mice were immunized a single time with 35-krad-irradiated or normal O. volvulus L3, there was a significant reduction in the survival of challenge parasites. However, there was little or no reduction in challenge worm survival when mice were immunized a single time with freeze-thaw-killed O. volvulus L3 or fourth-stage larva (L4), or irradiated O. lienalis L3. When a second dose of freeze-thaw killed O. volvulus L3 or irradiated O. lienalis L3 was administered, there was a significant reduction in parasite survival in immunized mice. Immunization with O. volvulus L4 or a combination of L3 and L4 failed to confer protection. These results demonstrate that mice can be immunized against larval O. volvulus and that diffusion chambers are an efficient method for studying protective immunity to this parasite in a mouse model.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8279644     DOI: 10.4269/ajtmh.1993.49.783

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  17 in total

1.  Brugia malayi: comparison of protective immune responses induced by Bm-alt-2 DNA, recombinant Bm-ALT-2 protein and prime-boost vaccine regimens in a jird model.

Authors:  Sivasakthivel Thirugnanam; Pandurangan Pandiaraja; Kalyanasundaram Ramaswamy; Vadivel Murugan; Munirathinam Gnanasekar; Krithika Nandakumar; Maryada Venkata Rami Reddy; Perumal Kaliraj
Journal:  Exp Parasitol       Date:  2007-03-06       Impact factor: 2.011

Review 2.  A comprehensive, model-based review of vaccine and repeat infection trials for filariasis.

Authors:  C Paul Morris; Holly Evans; Sasha E Larsen; Edward Mitre
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

3.  Vaccines to combat river blindness: expression, selection and formulation of vaccines against infection with Onchocerca volvulus in a mouse model.

Authors:  Jessica A Hess; Bin Zhan; Sandra Bonne-Année; Jessica M Deckman; Maria Elena Bottazzi; Peter J Hotez; Thomas R Klei; Sara Lustigman; David Abraham
Journal:  Int J Parasitol       Date:  2014-06-05       Impact factor: 3.981

Review 4.  Onchocerca volvulus: The Road from Basic Biology to a Vaccine.

Authors:  Sara Lustigman; Benjamin L Makepeace; Thomas R Klei; Simon A Babayan; Peter Hotez; David Abraham; Maria Elena Bottazzi
Journal:  Trends Parasitol       Date:  2017-09-22

5.  Development of a recombinant antigen vaccine against infection with the filarial worm Onchocerca volvulus.

Authors:  D Abraham; O Leon; S Leon; S Lustigman
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

6.  Identification of potential vaccine and drug target candidates by expressed sequence tag analysis and immunoscreening of Onchocerca volvulus larval cDNA libraries.

Authors:  M Lizotte-Waniewski; W Tawe; D B Guiliano; W Lu; J Liu; S A Williams; S Lustigman
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Immunity to onchocerciasis: cells from putatively immune individuals produce enhanced levels of interleukin-5, gamma interferon, and granulocyte-macrophage colony-stimulating factor in response to Onchocerca volvulus larval and male worm antigens.

Authors:  P S Turaga; T J Tierney; K E Bennett; M C McCarthy; S C Simonek; P A Enyong; D W Moukatte; S Lustigman
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

8.  In a bovine model of onchocerciasis, protective immunity exists naturally, is absent in drug-cured hosts, and is induced by vaccination.

Authors:  Virginia L Tchakouté; Simon P Graham; Siv Aina Jensen; Benjamin L Makepeace; Charles K Nfon; Leo M Njongmeta; Sara Lustigman; Peter A Enyong; Vincent N Tanya; Albert E Bianco; Alexander J Trees
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-03       Impact factor: 11.205

9.  Onchocerca volvulus larval antigen, OvB20, induces partial protection in a rodent model of onchocerciasis.

Authors:  M J Taylor; N Abdel-Wahab; Y Wu; R E Jenkins; A E Bianco
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

10.  Immunoglobulin E and eosinophil-dependent protective immunity to larval Onchocerca volvulus in mice immunized with irradiated larvae.

Authors:  David Abraham; Ofra Leon; Silvia Schnyder-Candrian; Chun Chi Wang; Ann Marie Galioto; Laura A Kerepesi; James J Lee; Sara Lustigman
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.